US Stock MarketDetailed Quotes

BMY Bristol-Myers Squibb

Watchlist
  • 50.200
  • +0.980+1.99%
Close Apr 30 16:00 ET
  • 50.120
  • -0.080-0.16%
Post 20:01 ET
102.16BMarket Cap18.73P/E (TTM)

Bristol-Myers Squibb Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
Total revenue
-5.60%11.2B
7.32%48.3B
7.54%12.34B
8.44%11.89B
8.69%12.2B
4.66%11.87B
-2.50%45.01B
0.62%11.48B
-2.25%10.97B
-5.56%11.23B
Operating revenue
-6.15%10.97B
6.47%47.26B
5.48%11.94B
7.47%11.59B
8.52%12.04B
4.48%11.69B
-2.26%44.39B
0.60%11.32B
-1.85%10.78B
-5.03%11.1B
Cost of revenue
3.44%3.03B
30.63%13.97B
75.30%4.81B
18.00%2.96B
13.60%3.27B
14.26%2.93B
5.48%10.69B
5.86%2.75B
6.50%2.51B
5.74%2.88B
Gross profit
-8.56%8.17B
0.06%34.33B
-13.77%7.53B
5.61%8.94B
6.99%8.93B
1.85%8.93B
-4.74%34.31B
-0.92%8.73B
-4.57%8.46B
-8.91%8.35B
Operating expense
-37.04%4.67B
8.91%28.45B
2.80%7.02B
4.03%6.76B
12.31%7.24B
17.04%7.42B
-2.97%26.12B
-4.07%6.83B
-3.92%6.5B
-1.16%6.45B
Selling and administrative expenses
-33.08%1.58B
8.26%8.41B
3.04%2.14B
-1.00%1.98B
-0.31%1.93B
34.34%2.37B
-0.54%7.77B
-8.52%2.07B
3.78%2B
8.23%1.93B
-Selling and marketing expense
-33.08%1.58B
----
----
-1.00%1.98B
----
34.34%2.37B
----
----
3.78%2B
----
Research and development costs
-16.25%2.26B
20.00%11.16B
28.77%3.19B
5.89%2.37B
28.39%2.9B
16.11%2.7B
-2.21%9.3B
-1.27%2.48B
-7.28%2.24B
-2.71%2.26B
Depreciation amortization depletion
-64.79%830M
-1.93%8.87B
-25.68%1.69B
6.65%2.41B
7.04%2.42B
4.48%2.36B
-5.71%9.05B
-2.77%2.28B
-6.70%2.26B
-6.62%2.26B
-Depreciation and amortization
-64.79%830M
-1.93%8.87B
-25.68%1.69B
6.65%2.41B
7.04%2.42B
4.48%2.36B
-5.71%9.05B
-2.77%2.28B
-6.70%2.26B
-6.62%2.26B
Operating profit
130.98%3.5B
-28.16%5.89B
-73.20%510M
10.87%2.17B
-11.05%1.69B
-37.75%1.51B
-9.98%8.2B
12.34%1.9B
-6.67%1.96B
-28.05%1.9B
Net non-operating interest income expense
-16.24%-494M
-66.98%-1.95B
-56.96%-496M
-80.36%-505M
-84.75%-521M
-47.57%-425M
5.36%-1.17B
-7.48%-316M
6.35%-280M
9.90%-282M
Non-operating interest expense
16.24%494M
66.98%1.95B
56.96%496M
80.36%505M
84.75%521M
47.57%425M
-5.36%1.17B
7.48%316M
-6.35%280M
-9.90%282M
Other net income (expense)
99.74%-33M
-973.07%-12.32B
85.06%161M
-98.03%9M
-51.67%116M
-2,113.58%-12.61B
987.42%1.41B
-81.05%87M
11.98%458M
164.69%240M
Gain on sale of security
-78.95%60M
70.93%494M
-145.96%-91M
-0.93%106M
424.32%194M
637.74%285M
145.87%289M
-19.84%198M
181.58%107M
113.17%37M
Special income (charges)
95.33%-621M
-3,968.09%-13.38B
642.98%899M
-87.65%-456M
-65.94%-536M
-11,557.76%-13.29B
54.99%-329M
-76.82%121M
-18.54%-243M
42.32%-323M
-Less:Restructuring and merger&acquisition
-97.26%364M
824.10%14.34B
-76.02%177M
48.73%409M
41.52%467M
6,258.37%13.29B
16.69%1.55B
350.00%738M
70.81%275M
-39.34%330M
-Less:Impairment of capital assets
----
62.07%47M
--0
62.07%47M
----
----
--29M
--0
--29M
----
-Less:Other special charges
12,750.00%257M
121.54%84M
333.33%13M
----
1,085.71%69M
100.62%2M
-187.84%-390M
-97.95%3M
-238.64%-61M
-143.75%-7M
-Gain on sale of business
----
26.33%1.09B
----
----
----
----
-17.35%862M
----
----
----
Other non- operating income (expenses)
31.67%528M
-60.65%571M
-178.88%-647M
-39.56%359M
-12.93%458M
-28.77%401M
20.72%1.45B
25.16%-232M
3.13%594M
11.91%526M
Income before tax
125.80%2.97B
-199.28%-8.38B
-89.55%175M
-21.57%1.68B
-30.82%1.29B
-515.74%-11.52B
9.43%8.44B
-9.95%1.67B
-3.26%2.14B
-5.06%1.86B
Income tax
29.85%509M
38.50%554M
212.50%99M
127.09%461M
-82.57%-398M
-22.07%392M
-70.76%400M
46.99%-88M
-66.22%203M
-141.21%-218M
Net income
120.68%2.46B
-211.11%-8.93B
-95.69%76M
-37.18%1.22B
-18.92%1.68B
-625.28%-11.91B
26.71%8.04B
-12.99%1.76B
20.27%1.93B
45.35%2.08B
Net income continuous Operations
120.68%2.46B
-211.11%-8.93B
-95.69%76M
-37.18%1.22B
-18.92%1.68B
-625.28%-11.91B
26.71%8.04B
-12.99%1.76B
20.27%1.93B
45.35%2.08B
Minority interest income
100.00%6M
0.00%15M
4M
-33.33%4M
0.00%4M
-40.00%3M
-16.67%15M
0
200.00%6M
-50.00%4M
Net income attributable to the parent company
120.62%2.46B
-211.50%-8.95B
-95.91%72M
-37.19%1.21B
-18.96%1.68B
-626.57%-11.91B
26.84%8.03B
-12.86%1.76B
20.05%1.93B
45.88%2.07B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
120.62%2.46B
-211.50%-8.95B
-95.91%72M
-37.19%1.21B
-18.96%1.68B
-626.57%-11.91B
26.84%8.03B
-12.86%1.76B
20.05%1.93B
45.88%2.07B
Basic earnings per share
120.54%1.21
-213.66%-4.41
-95.40%0.04
-36.17%0.6
-16.16%0.83
-645.37%-5.89
30.64%3.88
-9.38%0.87
25.33%0.94
47.76%0.99
Diluted earnings per share
120.37%1.2
-214.25%-4.41
-95.40%0.04
-35.48%0.6
-16.16%0.83
-650.47%-5.89
30.85%3.86
-8.42%0.87
24.00%0.93
50.00%0.99
Dividend per share
3.33%0.62
4.76%2.42
3.33%0.62
5.26%0.6
5.26%0.6
5.26%0.6
5.48%2.31
5.26%0.6
5.56%0.57
5.56%0.57
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023
Total revenue -5.60%11.2B7.32%48.3B7.54%12.34B8.44%11.89B8.69%12.2B4.66%11.87B-2.50%45.01B0.62%11.48B-2.25%10.97B-5.56%11.23B
Operating revenue -6.15%10.97B6.47%47.26B5.48%11.94B7.47%11.59B8.52%12.04B4.48%11.69B-2.26%44.39B0.60%11.32B-1.85%10.78B-5.03%11.1B
Cost of revenue 3.44%3.03B30.63%13.97B75.30%4.81B18.00%2.96B13.60%3.27B14.26%2.93B5.48%10.69B5.86%2.75B6.50%2.51B5.74%2.88B
Gross profit -8.56%8.17B0.06%34.33B-13.77%7.53B5.61%8.94B6.99%8.93B1.85%8.93B-4.74%34.31B-0.92%8.73B-4.57%8.46B-8.91%8.35B
Operating expense -37.04%4.67B8.91%28.45B2.80%7.02B4.03%6.76B12.31%7.24B17.04%7.42B-2.97%26.12B-4.07%6.83B-3.92%6.5B-1.16%6.45B
Selling and administrative expenses -33.08%1.58B8.26%8.41B3.04%2.14B-1.00%1.98B-0.31%1.93B34.34%2.37B-0.54%7.77B-8.52%2.07B3.78%2B8.23%1.93B
-Selling and marketing expense -33.08%1.58B---------1.00%1.98B----34.34%2.37B--------3.78%2B----
Research and development costs -16.25%2.26B20.00%11.16B28.77%3.19B5.89%2.37B28.39%2.9B16.11%2.7B-2.21%9.3B-1.27%2.48B-7.28%2.24B-2.71%2.26B
Depreciation amortization depletion -64.79%830M-1.93%8.87B-25.68%1.69B6.65%2.41B7.04%2.42B4.48%2.36B-5.71%9.05B-2.77%2.28B-6.70%2.26B-6.62%2.26B
-Depreciation and amortization -64.79%830M-1.93%8.87B-25.68%1.69B6.65%2.41B7.04%2.42B4.48%2.36B-5.71%9.05B-2.77%2.28B-6.70%2.26B-6.62%2.26B
Operating profit 130.98%3.5B-28.16%5.89B-73.20%510M10.87%2.17B-11.05%1.69B-37.75%1.51B-9.98%8.2B12.34%1.9B-6.67%1.96B-28.05%1.9B
Net non-operating interest income expense -16.24%-494M-66.98%-1.95B-56.96%-496M-80.36%-505M-84.75%-521M-47.57%-425M5.36%-1.17B-7.48%-316M6.35%-280M9.90%-282M
Non-operating interest expense 16.24%494M66.98%1.95B56.96%496M80.36%505M84.75%521M47.57%425M-5.36%1.17B7.48%316M-6.35%280M-9.90%282M
Other net income (expense) 99.74%-33M-973.07%-12.32B85.06%161M-98.03%9M-51.67%116M-2,113.58%-12.61B987.42%1.41B-81.05%87M11.98%458M164.69%240M
Gain on sale of security -78.95%60M70.93%494M-145.96%-91M-0.93%106M424.32%194M637.74%285M145.87%289M-19.84%198M181.58%107M113.17%37M
Special income (charges) 95.33%-621M-3,968.09%-13.38B642.98%899M-87.65%-456M-65.94%-536M-11,557.76%-13.29B54.99%-329M-76.82%121M-18.54%-243M42.32%-323M
-Less:Restructuring and merger&acquisition -97.26%364M824.10%14.34B-76.02%177M48.73%409M41.52%467M6,258.37%13.29B16.69%1.55B350.00%738M70.81%275M-39.34%330M
-Less:Impairment of capital assets ----62.07%47M--062.07%47M----------29M--0--29M----
-Less:Other special charges 12,750.00%257M121.54%84M333.33%13M----1,085.71%69M100.62%2M-187.84%-390M-97.95%3M-238.64%-61M-143.75%-7M
-Gain on sale of business ----26.33%1.09B-----------------17.35%862M------------
Other non- operating income (expenses) 31.67%528M-60.65%571M-178.88%-647M-39.56%359M-12.93%458M-28.77%401M20.72%1.45B25.16%-232M3.13%594M11.91%526M
Income before tax 125.80%2.97B-199.28%-8.38B-89.55%175M-21.57%1.68B-30.82%1.29B-515.74%-11.52B9.43%8.44B-9.95%1.67B-3.26%2.14B-5.06%1.86B
Income tax 29.85%509M38.50%554M212.50%99M127.09%461M-82.57%-398M-22.07%392M-70.76%400M46.99%-88M-66.22%203M-141.21%-218M
Net income 120.68%2.46B-211.11%-8.93B-95.69%76M-37.18%1.22B-18.92%1.68B-625.28%-11.91B26.71%8.04B-12.99%1.76B20.27%1.93B45.35%2.08B
Net income continuous Operations 120.68%2.46B-211.11%-8.93B-95.69%76M-37.18%1.22B-18.92%1.68B-625.28%-11.91B26.71%8.04B-12.99%1.76B20.27%1.93B45.35%2.08B
Minority interest income 100.00%6M0.00%15M4M-33.33%4M0.00%4M-40.00%3M-16.67%15M0200.00%6M-50.00%4M
Net income attributable to the parent company 120.62%2.46B-211.50%-8.95B-95.91%72M-37.19%1.21B-18.96%1.68B-626.57%-11.91B26.84%8.03B-12.86%1.76B20.05%1.93B45.88%2.07B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 120.62%2.46B-211.50%-8.95B-95.91%72M-37.19%1.21B-18.96%1.68B-626.57%-11.91B26.84%8.03B-12.86%1.76B20.05%1.93B45.88%2.07B
Basic earnings per share 120.54%1.21-213.66%-4.41-95.40%0.04-36.17%0.6-16.16%0.83-645.37%-5.8930.64%3.88-9.38%0.8725.33%0.9447.76%0.99
Diluted earnings per share 120.37%1.2-214.25%-4.41-95.40%0.04-35.48%0.6-16.16%0.83-650.47%-5.8930.85%3.86-8.42%0.8724.00%0.9350.00%0.99
Dividend per share 3.33%0.624.76%2.423.33%0.625.26%0.65.26%0.65.26%0.65.48%2.315.26%0.65.56%0.575.56%0.57
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Market Insights

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More